Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 6266 of 6351
-
Healthy volunteers test new gout drug combo in early safety trial
Knowledge-focused CompletedA Phase 1 Study to evaluate the safety, PK/PD, drug-drug interaction(DDI) of Epaminurad and Naproxen in Healthy Volunteers
Phase 1 • Sponsor: JW Pharmaceutical • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:08 UTC
-
New drug AMN1126 put through early safety testing
Knowledge-focused CompletedThis is an Open-label, Sequential dosing, Single Ascending Dose (SAD) Study to Determine the Safety, Tolerability, and Pharmacokinetic (PK) Profile of KSHN001126 in Healthy Human Post-Menopausal Female Volunteers. The primary objective of the study is to evaluate the safety and t…
Phase 1 • Sponsor: Amneal Pharmaceuticals, LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Light therapy tested for Post-Mastectomy nerve pain – but study never started
Symptom relief CancelledThe goal of this case study is to examine the effects of Photobiomodulation (PBM) on neuropathic pain and sensation post-mastectomy in one female participant. Neuropathic pain and somatosensation will be primary measures, along with strength, range of motion testing, and measures…
Sponsor: Tufts University • Aim: Symptom relief
Last updated Jun 26, 2026 14:31 UTC
-
Scrolling instagram for 30 minutes changes neck function in athletes
Knowledge-focused CompletedThe aim of this study is to examine the effect of mental fatigue (MF) induced by 30 minutes of social media use on neck kinematics and neck muscle biomechanical properties in young male athletes. Twenty-five participants are enrolled in a single-blind cross-sectional design. Base…
Sponsor: Bandırma Onyedi Eylül University • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:01 UTC
-
Withdrawn before start: experimental cocktail for type 1 diabetes never tested
Disease control CancelledTo assess whether there is a difference in endogenous insulin secretion, measured as stimulated C-peptide secretion (area under the curve during a 4-hour mixed meal tolerance test), at the 1 year visit, for study subjects receiving combinational therapy versus those receiving pla…
Phase 1/2 • Sponsor: Camillo Ricordi and Jay Skyler • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Pain relief study for cancer patients withdrawn before starting
Symptom relief Cancelledthe goal of this clinical trial is to compare in cancer patients: Is ultrasound-guided percutaneous neuromodulation useful for lower limb pain relief in cancer patients? Is direct current transcranial stimulation useful for relieving lower limb pain in cancer patients? Partici…
Sponsor: Universidad Europea de Canarias • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
Feeding study pulled before it began
Knowledge-focused CancelledEvaluation of three online modules developed by the Center for Childhood Obesity Research for caregivers of children ages 5-12 years old participating in SNAP-Ed programing.
Sponsor: Penn State University • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
VR headsets may mess with your memory, study finds
Knowledge-focused CompletedThe effect of virtual reality on memory.
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 26, 2026 17:25 UTC
-
Breakfast or not? study tests Food's impact on new pill
Knowledge-focused CompletedThis study is a single-dose, randomized, open-label, three-sequence, three-period crossover clinical trial to evaluate the effect of high-fat and low-fat meals on the pharmacokinetics of ammoxetine hydrochloride enteric-coated tablets in healthy subjects.
Phase 1 • Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
New study explores link between breastfeeding views and nutrition Know-How
Knowledge-focused CompletedThe importance of breast milk, whose physiological nutritional properties for an infant are not equal to any other food, has been the subject of many studies. In this study, it is aimed to evaluate the relationship between breastfeeding attitude and nutritional knowledge levels o…
Sponsor: Nigde Omer Halisdemir University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
What drives healthy eating? new study explores young Adults' minds
Knowledge-focused CompletedIn this project, eating awareness, acceptance of food cravings, healthy life awareness and health perception will be examined in healthy young adults.
Sponsor: Nigde Omer Halisdemir University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Low-Dose creatine hydrochloride shows promise in small safety study
Knowledge-focused CompletedBackground: Creatine monohydrate (typically 5-20 g/day) has a well-established safety profile across diverse populations. Creatine hydrochloride (CR-HCl) is a highly soluble creatine formulation that may allow effective supplementation at substantially lower doses (750 mg - 3 g/d…
Sponsor: Vireo Systems, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:06 UTC
-
Breakfast vs. fasting: new study tests how a meal changes drug levels
Knowledge-focused CompletedThe main objective is to investigate the effect of food on the pharmacokinetics of BI 1015550 Formulation C2.
Phase 1 • Sponsor: Boehringer Ingelheim • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:00 UTC
-
New drug DA-7503 tested in healthy volunteers for safety
Knowledge-focused CompletedThis is a double-blind, placebo-controlled, randomized, phase 1 study to evaluate safety, tolerability, and pharmacokinetics of orally administered DA-7503 after single and multiple ascending dose regimens in healthy adult and elderly participants
Phase 1 • Sponsor: Dong-A ST Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:36 UTC
-
Diabetes drug absorption study completed in 24 healthy volunteers
Knowledge-focused CompletedThis study was designed as a a single-center, randomized, open, interleaved (3-cycle, 3-sequence) trial. It is planned to enroll 18 healthy subjects.
Phase 1 • Sponsor: Shandong Suncadia Medicine Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:24 UTC
-
New drug ZE50-0134 passes first safety check in healthy people
Knowledge-focused CompletedA first-in-human study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple ascending doses of ZE50-0134 administered orally in healthy volunteers.
Phase 1 • Sponsor: Lomond Therapeutics Holdings, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC
-
Hysterectomy study abandoned after just one patient
Knowledge-focused Stopped earlyBenign total hysterectomy is one of the most commonly performed gynecological surgery. Conventionally performed by a classical surgical approach, it is now provided routinely and for several years by laparoscopy and more recently by Robotic-Assisted Laparoscopy. A third minimal…
Sponsor: Elsan • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Healthy volunteers help uncover calderasib drug interactions
Knowledge-focused CompletedThe goal of this study is to learn what happens to calderasib in a healthy person's body over time, called a pharmacokinetic (PK) study. Researchers want to compare the amount of calderasib when it is taken as a single dose; with multiple doses of itraconazole, or with multiple d…
Phase 1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Healthy volunteers test new breathing devices to see how flow changes lung function
Knowledge-focused CompletedThis prospective, randomized crossover trial will enroll adult healthy volunteers. Initially, the subject's peak inspiratory flow will be measured using a mask connected with a respiratory monitor. Subsequently, the volunteers will undergo HFNC treatment at different flow setting…
Sponsor: Rush University Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
New drug IRL757 passes first safety check in healthy humans
Knowledge-focused CompletedThis is a Phase 1, First-In-Human study evaluating the safety and tolerability of single and multiple ascending oral doses of IRL757 in healthy volunteers.
Phase 1 • Sponsor: Integrative Research Laboratories AB • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC